AffirmHealth Blog

Jody Lutz


Recent Posts

New York's Drug Take Back Act

Posted by Jody Lutz on Jan 23, 2019 3:19:42 PM

0 Comments

A report released in November of 2018, from the Centers for Disease Control and Prevention, show that drug overdoses killed a record number of more than 70,000 Americans in 2017. To put this phenomenon into perspective, drug overdose deaths are higher than deaths from H.I.V., car crashes, or gun violence at their peaks.

We at AffirmHealth report often about the nationwide epidemic, but today we take a closer look at the state of New York. In 2015, New York prescribers wrote 10.2 million opioid prescriptions or 51.3 prescriptions per 100 patients–a 7.8 percent decline since 2013. This is also less than the national rate of 71 prescriptions per 100 patients (IMS Health).

READ MORE

Opioids: A Global perspective. Treating Pain and Battling Addiction.

Posted by Jody Lutz on Jan 2, 2019 2:34:09 PM

0 Comments

The Opioid Epidemic in America is a topic covered extensively, each and every day in the news. AffirmHealth covers this topically frequently as well, most recently in our, "Where are We Now?" article.

READ MORE

Teens and Opioid Abuse

Posted by Jody Lutz on Dec 18, 2018 3:34:22 PM

0 Comments

 

Historically, research has shown that nearly 1 in 4 high school  seniors  in the United States have been exposed to prescription opioids through either medical or non-medical use. On November 12, 2018 a JAMA abstract reported: Between 1997 and 2012, the rate of hospitalization due to opioid poisonings nearly doubled in US children and adolescents. Opioid use early in life is associated with a higher likelihood of opioid misuse in the future.
READ MORE

The Future of Managing Pain: Novel Treatments & Reformulations

Posted by Jody Lutz on Nov 28, 2018 2:26:19 PM

0 Comments

As the opioid misuse and overdose epidemic impacts communities across America and has sweeping global implications, practitioners are looking to the future of pain management and the novel treatment options that may be on the horizon.

READ MORE

MIPS and Improvement Activity Data

Posted by Jody Lutz on Nov 13, 2018 3:28:24 PM

0 Comments

Last week on the AffirmHealth Blog we discussed MIPS and PDMP Usage and promised a follow up on additional Improvement Activities. So this week we look at an Improvement Activities Data overview as well as a handful of activities potentially pertinent to providers prescribing opioids or other controlled substances.

Let’s start at the beginning…

READ MORE

MIPS and PDMP Usage: How they work together.

Posted by Jody Lutz on Oct 30, 2018 12:46:41 PM

0 Comments

MIPS: What is it and what do prescribers need to know? 

READ MORE

Naloxone and Buprenorphine...Access and Accessibility in America

Posted by Jody Lutz on Oct 16, 2018 3:25:41 PM

0 Comments

 

Naloxone is a medication approved by the Food and Drug Administration (FDA) to prevent overdose by opioids it is designed to rapidly reverse opioid overdose. Commercially, it has been available for almost 50 years and several formulations are available, produced by various manufacturers. 

READ MORE

The Opioid Misuse Situation

Posted by Jody Lutz on Oct 9, 2018 9:36:16 AM

0 Comments

Everyday the media is flooded with stories about the toll of opioid addiction in America. New rules and regulations are regularly being introduced on a state and national level as we collectively grapple with how to tackle this epidemic. However, the war on opioids in America is not new. In 2011, the Centers for Disease Control warned that prescription painkiller overdoses had reached what was considered “epidemic levels.”

READ MORE

 

The information presented on or through this website is made available solely for general information purposes and is not intended to substitute for professional, medical or legal advice. We do not warrant the accuracy, completeness, or usefulness of this information. Any reliance you place on such information is strictly at your own risk. We disclaim all liability and responsibility arising from any reliance placed on such materials.

PROTECT YOUR PATIENTS.
PROTECT YOUR PRACTICE.

Drive responsible, compliant opioid prescribing across your organization.

SCHEDULE A CALL

Comments

Categories

see all

Popular Posts